- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Syngene International Limited — Updates, 22-01-2026: Press Release
22-01-2026 | 06:36 pm
22-01-2026 | 06:36 pm
Syngene's Q3 revenue fell 3% to 917 Cr, with PAT down 44% to 72.9 Cr, impacted by a single client. 9M revenue rose 3% to 2,702 Cr. Major win: Bristol Myers Squibb partnership extended to 2035, broadening service scope. New manufacturing facilities commissioned.
No comments yet. Be the first to comment!